Sputum neutrophil elastase and inhaled antibiotic response in bronchiectasis: a post-hoc analysis of the ORBIT-4 trial

H. Abo-Leyah (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), T. Pembridge (Dundee, United Kingdom), Y. Gao (Dundee, United Kingdom), P. Goeminne (Sint-Niklaas, Belgium), C. Haworth (Cambridge, United Kingdom), J. Chalmers (Dundee, United Kingdom)

Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Session: Bronchiectasis heterogeneity: assessing the endotypes
Session type: Oral Presentation
Number: 1310

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Abo-Leyah (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), T. Pembridge (Dundee, United Kingdom), Y. Gao (Dundee, United Kingdom), P. Goeminne (Sint-Niklaas, Belgium), C. Haworth (Cambridge, United Kingdom), J. Chalmers (Dundee, United Kingdom). Sputum neutrophil elastase and inhaled antibiotic response in bronchiectasis: a post-hoc analysis of the ORBIT-4 trial. 1310

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhaled antibiotics improve symptoms of cough and sputum in patients with bronchiectasis: a post-hoc analysis of the AIR-BX studies
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis
Source: International Congress 2017 – Current challenges in COPD evaluation
Year: 2017


Sputum neutrophil elastase in bronchiectasis: a Southern European cohort study
Source: Eur Respir J, 56 (6) 2001702; 10.1183/13993003.01702-2020
Year: 2020



The effect of azithromycin on sputum inflammatory markers in bronchiectasis – analysis of a randomized controlled trial
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019



Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002

Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum
Source: Annual Congress 2004 - Role of infection in COPD
Year: 2004


Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis
Source: Eur Respir J 2014; 44: 789-791
Year: 2014


Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition
Source: ERJ Open Res, 5 (1) 00252-2018; 10.1183/23120541.00252-2018
Year: 2019



Chronic eosinophilic pneumonia: clinical study, analysis of BAL, tryptase assay
Source: Eur Respir J 2003; 22: Suppl. 45, 177s
Year: 2003

Late-breaking abstract: Repeated analysis of alpha-1-antitrypsin concentrations in sputum, lavage and serum of smokers with and without COPD
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011


Blood eosinophils do not predict inhaled budesonide response in bronchiectasis
Source: Eur Respir J, 56 (3) 2002210; 10.1183/13993003.02210-2020
Year: 2020



Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD
Source: Eur Respir J 2007; 30: 472-478
Year: 2007



Comparison of different techniques to evaluate active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients
Source: International Congress 2019 – Complex respiratory infections in clinical practice
Year: 2019

Tolerance test for inhaled antibiotics in patients with chronic bronchial infection
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018



Assessment and evaluation of symptomatic steroid-naive asthmatics without sputum eosinophilia and their response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: 1364-1369
Year: 2002



Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids
Source: Eur Respir J 2001; 18: Suppl. 33, 531s
Year: 2001

Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD
Source: Eur Respir J 2013; 41: 248
Year: 2013


Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD
Source: Eur Respir J 2013; 41: 248-249
Year: 2013


Cytokines concentrations in induced sputum of mild COPD patients. Correlation to clinical response to inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 309s
Year: 2002

Effect of airway clearance techniques on the efficacy of the sputum induction procedure
Source: Eur Respir J 2005; 26: 904-908
Year: 2005